Russia's Sputnik V Is Found to Be 91.6% Effective, Providing Boost for Global Vaccination Effort

Russia has been one of the countries hardest hit by the pandemic, recording about 73,000 deaths and over 3.8 million infections over the past year. Meanwhile, there is widespread skepticism over the domestically developed Sputnik V vaccine, with many Russians reluctant to get the shot.

Now a peer-reviewed study published in the respected Lancet medical journal has confirmed the vaccine's 91.6% efficacy, as developers of the shot have long maintained.

"That's good news for the developers of the vaccine in Russia. That's good news for Russia writ large, which certainly has plenty of geopolitical ambitions surrounding the vaccine," says Joshua Yaffa, a correspondent for The New Yorker in Moscow. "And it's frankly good news for the world."

Democracy Now! produces a daily, global, independent news hour hosted by award-winning journalists Amy Goodman and Juan González.

Our reporting includes breaking daily news headlines and in-depth interviews with people on the front lines of the world’s most pressing issues.

On DN!, you’ll hear a diversity of voices speaking for themselves, providing a unique and sometimes provocative perspective on global events.

Missed an episode? Check out DN on FSTV VOD anytime or visit the show page for the latest clips.

#FreeSpeechTV is one of the last standing national, independent news networks committed to advancing progressive social change.

#FSTV is available on Dish, DirectTV , AppleTV, Roku, Sling, and online at freespeech.org.